Technology, pharmaceutical and biotech companies' acquisitions of tiny but innovative challengers have created "unease" at the EU's merger regulator, the bloc's competition boss said today as she outlined an expansion to the EU's powers to review deals."We have an increasing unease with the kind of transaction where you have a really big